US Map / Indiana
State IN

Clinical Trials in Indiana

Recruiting clinical trials with at least one study location in Indiana. Data updated daily from ClinicalTrials.gov.

Total Trials
171
Recruiting Now
171
← Back to US Map
Top Conditions in Indiana
Prostate Cancer (7)Breast Cancer (6)Malignant Solid Neoplasm (4)Melanoma (3)Ovarian Cancer (3)Endometrial Cancer (3)Acute Myeloid Leukemia (3)Atopic Dermatitis (3)Atrial Fibrillation (3)Lung Non-Small Cell Carcinoma (2)Non-small Cell Lung Cancer (2)Sarcoma (2)
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT04506593 N/A
Recruiting
Indiana University Gastrointestinal Motility Diagnosis Registry
Condition
Eosinophilic Esophagitis
Enrollment
5,000 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06955169 Phase 2
Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care ...
Condition
Intracranial Meningioma
Enrollment
153 pts
Location
United States
Sponsor
RTOG Foundation, Inc.
View Trial →
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT07353931 Phase 3
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthri...
Condition
Osteoarthritis
Enrollment
900 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT04862221 Phase 2
Recruiting
TReatment for ImmUne Mediated PathopHysiology
Condition
Acute Liver Failure
Enrollment
163 pts
Location
United States
Sponsor
National Institute of Diabetes
View Trial →
NCT04700657 N/A
Recruiting
The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Diseas...
Condition
Ocular GVHD
Enrollment
30 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05866081 N/A
Recruiting
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Sur...
Condition
Stone, Kidney
Enrollment
792 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT05844501 Phase 4
Recruiting
Ondansetron for the Management of Atrial Fibrillation
Condition
Atrial Fibrillation
Enrollment
80 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06689839 N/A
Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Condition
Aortic Stenosis Treated With TAVI
Enrollment
500 pts
Location
United States, Australia
Sponsor
EnCompass Technologies, Inc.
View Trial →
NCT06966700 Phase 3
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Br...
Condition
Breast Neoplasms
Enrollment
2,400 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05285553 N/A
Recruiting
MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms
Condition
Myopia
Enrollment
900 pts
Location
United States
Sponsor
CooperVision, Inc.
View Trial →
NCT07048392 N/A
Recruiting
Retrieval-Based Word Learning in Developmental Language Disorder During Book Rea...
Condition
Developmental Language Disorder and Language Impairment
Enrollment
32 pts
Location
United States
Sponsor
Purdue University
View Trial →
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
View Trial →
NCT06500780 N/A
Recruiting
Equipping Patients Using Interventions for Pain and Depression
Condition
Chronic Pain
Enrollment
304 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06728293 N/A
Recruiting
Effect of the HCC Liver-Link Intervention
Condition
HCC
Enrollment
40 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT05813678 N/A
Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALac...
Condition
Phenylketonuria (PKU)
Enrollment
450 pts
Location
United States, Germany, Italy
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06276491 Phase 1
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Condition
Ovarian Cancer
Enrollment
282 pts
Location
United States
Sponsor
Xencor, Inc.
View Trial →
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
View Trial →
NCT06586515 Phase 1
Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tum...
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
630 pts
Location
United States, Canada, China
Sponsor
Eli Lilly and Company
View Trial →
NCT07449923 Phase 3
Recruiting
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1...
Condition
Diabetic Macular Edema
Enrollment
240 pts
Location
United States
Sponsor
EyePoint Pharmaceuticals, Inc.
View Trial →
Page 6 of 7 — 171 trials total
← Prev Next →